KorrekturQualitative StudieOpen Access · CC BY 4.0
Correction to: Patients’ and healthcare providers’ views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study
The Oncologist · 05.11.2026 · 31 (12)
DOI: 10.1093/oncolo/oyag442 ↗Kurz gefasst
Korrektur in der Zeitschrift The Oncologist, online erschienen am 13.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to: Patients’ and healthcare providers’ views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study. The Oncologist, 31(12). https://doi.org/10.1093/oncolo/oyag442
Vancouver
Correction to: Patients’ and healthcare providers’ views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study. The Oncologist. 2026;31(12). doi:10.1093/oncolo/oyag442
BibTeX
@article{euvimed2026,
title = {Correction to: Patients’ and healthcare providers’ views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {12},
doi = {10.1093/oncolo/oyag442}
}
EUVIMED